{"title":"Antimalarial drug efficacy (2015)","nid":760,"vid":4276,"created":1622112690,"changed":1626693429,"field_accordian_header":[{"field_accordian":[{"field_title":"National drug and regulatory","field_content":"National drug and regulatory authorities should ensure that the antimalarial medicines provided in both the public and the private sectors are of acceptable quality, through regulation, inspection and law enforcement.<br>\n&nbsp;\n<p class=\"statement\" style=\"background-color:rgb( 102 , 204 , 255 );  padding-left: 15px; padding-right: 15px; padding-top: 8px; padding-bottom: 5px;\"><span style=\"color:#0000cd\"><em>Good practice statement<\/em><\/span><\/p><\/tbody>\n","justification":null,"practical_info":null,"field_icon":null}],"field_header":"Antimalarial drug quality&nbsp;(2015)"}],"field_content_type":{"tid":9,"name":"Accord","class":"accord"},"field_left_right_navigation":1,"field_operational_":[{"field_image":"","field_link":"","field_title":null}],"field_recommendations":1,"recommendation":"<p>All cases of suspected malaria should have a parasitological test (microscopy or Rapid diagnostic test (RDT)) to confirm the diagnosis.<br \/>\r\nBoth microscopy and RDTs should be supported by a quality assurance programme.<br \/>\r\n<font color=\"#4090CF\"><em>Good practice statement<\/em><\/font><\/p>\r\n","recommendation_title":"Rapid diagnostic test (RDT)","field_recommendation_api_url":"https:\/\/api.magicapp.org\/api\/v1\/recommendations\/?sectionId=78116","field_references":null,"field_tags":[{"tid":66,"name":"Recommendations for case management"},{"tid":42,"name":"Drug efficacy & resistance"}]}